News | Computed Tomography (CT) | November 23, 2015

CIRS Whole Body and Organ Dose Phantoms for Radiation Therapy

dosimetry phantoms

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Each phantom is sectional in design with traditional 25 mm thick sections. The sectional surfaces are extremely flat and smooth and do not require any special coatings or treatment. This results in minimal interfaces between the slabs when viewed in a scout or projection X-ray. The ATOM line also differs from other dosimetry phantoms by providing optimized TLD locations specific to 21 inner organs.

Tissue-equivalent epoxy resins are used in all aspects of the phantom. CIRS technology offers superior tissue simulation Dosimetry Verification Phantoms by covering a wider range of energy levels from diagnostic to therapeutic. In addition, all bones are homogeneous and are formulated to represent age appropriate, average bone composition. CIRS bone formulations offer distinct advantages over natural skeletons and other types of simulated bone. 

  • Phantom models cover a wide range of patient ages
  • Organ specific dosimetry with minimal detectors
  • Superior tissue simulation and lifelike imaging properties
  • Homogeneous bone
  • Accommodates wide variety of detectors
  • Age appropriate references

This product or an optional accessory of this product requires a CIRS dosimetry cavity code before an order can be placed. Please refer to the Dosimetry Cavity Codes document to identify the CIRS code for the probe you intend to use with this product.

For more information: www.cirsinc.com


Related Content

Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
News | Computed Tomography (CT)

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
News | Computed Tomography (CT)

July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical ...

Home July 20, 2023
Home
Subscribe Now